Focused Wealth Management’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-160
| Closed | -$14.3K | – | 935 |
|
|
2023
Q4 | $14.3K | Sell |
160
-288
| -64% | -$25.7K | ﹤0.01% | 482 |
|
|
2023
Q3 | $32.7K | Sell |
448
-18
| -4% | -$1.32K | 0.01% | 349 |
|
|
2023
Q2 | $38.8K | Sell |
466
-21
| -4% | -$1.75K | 0.01% | 343 |
|
|
2023
Q1 | $37.1K | Sell |
487
-41,779
| -99% | -$3.19M | 0.01% | 351 |
|
|
2022
Q4 | $3.51M | Buy |
42,266
+549
| +1% | +$45.6K | 0.71% | 26 |
|
|
2022
Q3 | $3.31M | Buy |
41,717
+595
| +1% | +$47.2K | 0.69% | 26 |
|
|
2022
Q2 | $3.05M | Sell |
41,122
-75
| -0.2% | -$5.57K | 0.56% | 35 |
|
|
2022
Q1 | $3.7M | Buy |
41,197
+3,870
| +10% | +$348K | 0.59% | 28 |
|
|
2021
Q4 | $4.18M | Buy |
37,327
+1,162
| +3% | +$130K | 0.65% | 25 |
|
|
2021
Q3 | $4.55M | Buy |
36,165
+1,087
| +3% | +$137K | 0.74% | 22 |
|
|
2021
Q2 | $4.75M | Buy |
35,078
+2,676
| +8% | +$362K | 0.78% | 22 |
|
|
2021
Q1 | $4.4M | Sell |
32,402
-3,969
| -11% | -$538K | 0.78% | 20 |
|
|
2020
Q4 | $5.12M | Buy |
36,371
+261
| +0.7% | +$36.7K | 1% | 16 |
|
|
2020
Q3 | $4.02M | Buy |
36,110
+549
| +2% | +$61.2K | 0.87% | 17 |
|
|
2020
Q2 | $3.98M | Buy |
35,561
+1,383
| +4% | +$155K | 0.92% | 17 |
|
|
2020
Q1 | $2.65M | Buy |
34,178
+34,114
| +53,303% | +$2.64M | 0.76% | 19 |
|
|
2019
Q4 | $6K | Buy |
+64
| New | +$6K | ﹤0.01% | 543 |
|